ORIGINAL RESEARCH article
Front. Pharmacol., 19 September 2019
Sec. Pharmacology of Anti-Cancer Drugs
Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.01071
RETRACTED: Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway
Chenghua Lou 1†
Yan Chen 1†
Jie Zhang 2
Bo Yang 1*
Huajun Zhao 1*
1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China
2. Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, United States
Summary
Citation
Lou C, Chen Y, Zhang J, Yang B and Zhao H (2019) RETRACTED: Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway. Front. Pharmacol. 10:1071. doi: 10.3389/fphar.2019.01071
Received
09 May 2019
Accepted
22 August 2019
Published
19 September 2019
Volume
10 - 2019
Edited by
Cyril Corbet, Catholic University of Louvain, Belgium
Reviewed by
Liang-Chuan Lai, National Taiwan University, Taiwan; Feng Gao, Washington University in St. Louis, United States
Updates
†These authors have contributed equally to this work
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.